HDAC9 and plasma cell myeloma: Importantly, HDAC inhibitors SAHA, pracrinostat, belinostat and romidepsin are FDA-approved drugs for some T-cell lymphomas [222,223,227,228], with panobinostat for multiple myeloma [229].